Browse by Aston Author

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | Date | No Grouping
Jump to: 2018 | 2016 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2002
Number of items: 22.

2018

Lattmann, Eric, Russell, Steven T, Singh, Mankaran, Narayanan, Ramesh, Balaram, Padinjarethalakal N. and Lattmann, Pornthip (2018). N‒substituted 5‒hydroxy‒pyrrol‒2‒ones based cholecystokinin‒2 antagonists as experimental anticancer agents for the treatment of lung cancer. Drug Design, Development and Therapy, 2 (4), pp. 180-189.

2016

Lattmann, E., Russell, S.T., Schwalbe, C.H., Shortt, A., Balaram, P.N., Theochari, E., Alharbi, M., Narayanan, R. and Lattmann, P. (2016). Cholecystokinin-1 receptor antagonists:5-hydroxy-5-aryl-pyrrol-2-ones as anticancer agents. MedChemComm, 7 (6), pp. 1138-1145.

2014

Claudius, Ann-Katrin, Kankipati, Chandra S., Kilari, Rajagopal S., Hassan, Sadiya, Guest, Kerry, Russell, Steven T., Perry, Chris J., Stark, Lesley A. and Nicholl, Iain D. (2014). Identification of aspirin analogues that repress NF-κB signalling and demonstrate anti-proliferative activity towards colorectal cancer in vitro and in vivo. Oncology Reports, 32 (4), pp. 1670-1680.

2012

Russell, Steven T. and Tisdale, Michael J. (2012). Role of β-adrenergic receptors in the oral activity of zinc-α2-glycoprotein (ZAG). Endocrinology, 153 (10), pp. 4696-4704.

Russell, Steven T. and Tisdale, Michael J. (2012). Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG). BBA - Molecular and Cell Biology of Lipids, 1821 (4), pp. 590-599.

2011

Russell, Steven and Tisdale, Michael (2011). Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat. International Journal of Obesity, 35 (5), pp. 658-665.

Russell, Steven and Tisdale, Michael (2011). Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse. International Journal of Obesity, 35 (3), pp. 345-354.

2010

Russell, Steven (2010). Adipokines have a role to play in the treatment of metabolic disease. Future Medicinal Chemistry, 2 (12), pp. 1721-1724.

Russell, Steven, Siren, Pontus M.A., Siren, Matus J. and Tisdale, Michael (2010). The role of zinc in the anti-tumour and anti-cachectic activity of D-myo-inositol 1,2,6-triphosphate. British Journal of Cancer, 102 (5), 833–836.

2009

Russell, Steve T., Siren, P.M.A., Siren, M.J. and Tisdale, Michael J. (2009). Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate. Cancer Chemotherapy and Pharmacology, 64 (3), pp. 517-527.

2008

Russell, Steve T., Eley, Helen L., Wyke, Stacey M. and Tisdale, Michael J. (2008). Involvement of phosphoinositide 3-kinase and Akt in the induction of muscle protein degradation by proteolysis-inducing factor. Biochemical Journal, 409 (Part 3), pp. 751-759.

2007

Eley, H., Russell, S.T. and Tisdale, M.J. (2007). Attenuation of muscle atrophy in a murine model of cachexia by inhibition of the dsRNA-dependent protein kinase. British Journal of Cancer, 96 (8), pp. 1216-1222.

2006

Bing, C., Russell, S., Becket, E., Pope, M., Tisdale, M.J., Trayhurn, P. and Jenkins, J.R. (2006). Adipose atrophy in cancer cachexia:morphologic and molecular analysis of adipose tissue in tumour-bearing mice. British Journal of Cancer, 95 (8), pp. 1028-1037.

2005

Khal, J., Wyke, S.M., Russell, Steve T., Hine, Anna V. and Tisdale, Michael J. (2005). Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia. British Journal of Cancer, 93 (7), pp. 774-780.

Sanders, P.M., Russell, S.T. and Tisdale, M.J. (2005). Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia. British Journal of Cancer, 93 (4), pp. 425-434.

Russell, Steve T. and Tisdale, Michael J. (2005). The role of glucocorticoids in the induction of zinc-α2-glycoprotein expression in adipose tissue in cancer cachexia. British Journal of Cancer, 92 (5), pp. 876-881.

2004

Wyke, S.M., Russell, Steve T. and Tisdale, Michael J. (2004). Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-κB activation. British Journal of Cancer, 91 (9), pp. 1742-1750.

Wynter, Michael P., Russell, Steve T. and Tisdale, Michael J. (2004). Effect of n-3 fatty acids on the antitumour effects of cytotoxic drugs. In Vivo, 18 (5), pp. 543-548.

2002

Russell, S.T. and Tisdale, M.J. (2002). Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo. British Journal of Cancer, 87 (5), pp. 580-584.

Russell, Steven T. (2002). The mode of action of a lipid mobilising factor in cancer cachexia. PHD thesis, Aston University.

Bing, C., Russell, S.T., Beckett, E.E., Collins, P., Taylor, S., Barraclough, R., Tisdale, M.J. and Williams, G. (2002). Expression of uncoupling proteins-1,-2 and-3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. British Journal of Cancer, 86 (4), pp. 612-618.

Russell, Steve T., Hirai, K. and Tisdale, Michael J. (2002). Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor. British Journal of Cancer, 86 (3), pp. 424-428.

This list was generated on Thu Apr 18 00:56:18 2019 BST.